AIHW publishes real per-PHN AODTS NMDS treatment-episode counts for the 2023-24 reporting year. Northern Sydney catchment received 2,941 treatment episodes — about 3.8 per 1,000 adults (national reference 11.6/1,000). The substance + treatment-type mix below is also from the AIHW release.
Real AODTS NMDS 2023-24 per-PHN episode mix by principal substance of concern. Substance grouping: alcohol; cannabis; amphetamines + ecstasy + cocaine + other stimulants; opioids (heroin, methadone, buprenorphine, oxycodone, morphine, codeine, other); other (nicotine, sedatives, not stated).
| Substance group | Share of episodes | Episodes / yr |
|---|---|---|
| Alcohol | 58.7% |
1,596
|
| Cannabis | 14.1% |
384
|
| Amphetamines / meth | 18.2% |
494
|
| Opioids (Rx + heroin) | 4.2% |
114
|
| Other (benzos, MDMA, polydrug) | 4.9% |
132
|
Episode counts + substance + treatment mix are from AIHW AODTS NMDS 2023-24 (real per-PHN). NOT published per-PHN by AIHW and intentionally omitted: risky-use prevalence (NDSHS national-only), 6.5% treatment-seeking assumption, derived service-gap math, AOD-related hospital separations per PHN, cohort-specific risky-use rates (youth, Indigenous, LGBTIQA+, CALD), per-LGA AOD data. The portal does not synthesise these — internal-data tier integrates direct AODTS extracts at unit-record level.
SNHN's portal was built in two weeks from public data + their LGA list. Yours can too — same shape, your colours, your data sources. From A$5k starter.